A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15462 ↗At a glance
Multizentrische Studie in Clinical Transplantation, 2024. Written by Mohammed Abul Kashem and 26 co-authors. Institution: Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: COVID-19, Lung Transplantation, SARS-CoV-2, Registries. Cited 1 times so far (Crossref); 24 references.
Abstract (original language)
Introduction
Lung transplantation has become increasingly utilized in patients with COVID‐19. While several single‐center and UNOS database studies have been published on lung transplants (LTs) for end‐stage lung disease (ESLD) from Coronavirus disease 2019 (COVID‐19), there is a lack of multi‐center and international data.
Methods
This is a multicenter analysis from 11 high‐volume lung transplant centers in the United States and Europe. Data were collected through the Multi‐Institutional ECLS Registry and stratified by ESLD due to COVID‐19 versus other etiologies. Demographics and clinical variables were compared using Chi‐square test and Fisher's exact test. Survival was assessed by Kaplan‐Meier curves and compared by log‐rank test with propensity score matching.
Results
Of 1606 lung transplant recipients, 46 (2.9%) were transplanted for ESLD from COVID‐19 compared to 1560 (97.1%) without a history of COVID‐19. Among COVID‐19 patients, 30 (65.2%) had COVID‐19‐associated ARDS and 16 (34.8%) had post‐COVID‐19 fibrosis. COVID‐19 patients had higher lung allocation scores (78.0 vs. 44.4, p < 0.0001), had severely limited functional status (37.0% vs. 2.9%, p < 0.0001), had higher preoperative ECMO usage (65.2% vs. 5.4%, p < 0.0001), and spent less time on the waitlist (32 vs. 137 days, p < 0.0001). A 30‐day survival was comparable between COVID‐19 and non‐COVID‐19 patients before (100% vs. 98.7%, p = 0.39) and after propensity matching ( p = 0.15).
Conclusions
Patients who received LTs due to COVID‐19 had short‐term survival comparable to that of patients without COVID‐19. Our findings support the idea that lung transplantation should be considered for select patients with ESLD due to COVID‐19.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
- Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.
- Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.
- Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
ORCID profiles: Gabriel Loor, Dirk Van Raemdonck, Hannah Calvelli, Marcelo Salan-Gomez, Jawad Salman, Pablo G Sanchez, Stephen Huddleston, Asishana Osho
Cite
APA
Kashem, M. A., Loor, G., Emtiazjoo, A., Hartwig, M., Van Raemdonck, D., Calvelli, H., Leon Pena, A., Salan-Gomez, M., Zhao, H., Warnick, M., Villavicencio, M., Ius, F., Ghadimi, K., Salman, J., Chandrashekaran, S., Machuca, T., Sanchez, P. G., Subramaniam, K., Neyrinck, A., …, & Toyoda, Y. (2024). A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19. Clinical Transplantation. https://doi.org/10.1111/ctr.15462
Vancouver
Kashem MA, Loor G, Emtiazjoo A, Hartwig M, Van Raemdonck D, Calvelli H, et al. A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19. Clinical Transplantation. 2024. doi:10.1111/ctr.15462
BibTeX
@article{Kashem2024,
author = {Kashem, Mohammed Abul and Loor, Gabriel and Emtiazjoo, Amir and Hartwig, Matthew and Van Raemdonck, Dirk and Calvelli, Hannah and Leon Pena, Andres and Salan-Gomez, Marcelo and Zhao, Huaqing and Warnick, Michael and Villavicencio, Mauricio and Ius, Fabio and Ghadimi, Kamrouz and Salman, Jawad and Chandrashekaran, Satish and Machuca, Tiago and Sanchez, Pablo G and Subramaniam, Kathirvel and Neyrinck, Arne and Huddleston, Stephen and Ceulemans, Laurens and Osho, Asishana and D'Silva, Ethan and Ramamurthy, Uma and Shaffer, Andrew and Langer, Nathaniel and Toyoda, Yoshiya},
title = {A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15462}
}
EUVIMED